Literature DB >> 27386922

Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor.

Jian Lei1, Guido Hansen2, Christoph Nitsche3, Christian D Klein3, Linlin Zhang1, Rolf Hilgenfeld4.   

Abstract

The ongoing Zika virus (ZIKV) outbreak is linked to severe neurological disorders. ZIKV relies on its NS2B/NS3 protease for polyprotein processing; hence, this enzyme is an attractive drug target. The 2.7 angstrom; crystal structure of ZIKV protease in complex with a peptidomimetic boronic acid inhibitor reveals a cyclic diester between the boronic acid and glycerol. The P2 4-aminomethylphenylalanine moiety of the inhibitor forms a salt-bridge with the nonconserved Asp(83) of NS2B; ion-pairing between Asp(83) and the P2 residue of the substrate likely accounts for the enzyme's high catalytic efficiency. The unusual dimer of the ZIKV protease:inhibitor complex seen in the crystal may provide a model for assemblies formed at high local concentrations of protease at the endoplasmatic reticulum membrane, the site of polyprotein processing.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27386922     DOI: 10.1126/science.aag2419

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  91 in total

Review 1.  Therapeutic Approaches for Zika Virus Infection of the Nervous System.

Authors:  Rachel P M Abrams; Jamie Solis; Avindra Nath
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 2.  On the cutting edge: protease-based methods for sensing and controlling cell biology.

Authors:  H Kay Chung; Michael Z Lin
Journal:  Nat Methods       Date:  2020-07-13       Impact factor: 28.547

3.  Mechanisms of activation and inhibition of Zika virus NS2B-NS3 protease.

Authors:  Xia Chen; Kailin Yang; Chen Wu; Cheng Chen; Can Hu; Olga Buzovetsky; Zefang Wang; Xiaoyun Ji; Yong Xiong; Haitao Yang
Journal:  Cell Res       Date:  2016-10-18       Impact factor: 25.617

4.  Zika Virus Protease Cleavage of Host Protein Septin-2 Mediates Mitotic Defects in Neural Progenitors.

Authors:  Hongda Li; Laura Saucedo-Cuevas; Ling Yuan; Danica Ross; Anide Johansen; Daniel Sands; Valentina Stanley; Alicia Guemez-Gamboa; Anne Gregor; Todd Evans; Shuibing Chen; Lei Tan; Henrik Molina; Nicholas Sheets; Sergey A Shiryaev; Alexey V Terskikh; Amy S Gladfelter; Sujan Shresta; Zhiheng Xu; Joseph G Gleeson
Journal:  Neuron       Date:  2019-01-31       Impact factor: 17.173

Review 5.  The Race To Find Antivirals for Zika Virus.

Authors:  Juan-Carlos Saiz; Miguel A Martín-Acebes
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

Review 6.  The versatility of boron in biological target engagement.

Authors:  Diego B Diaz; Andrei K Yudin
Journal:  Nat Chem       Date:  2017-07-25       Impact factor: 24.427

7.  Infectious disease: 3D structure of Zika virus protease.

Authors:  Sarah Crunkhorn
Journal:  Nat Rev Drug Discov       Date:  2016-08-30       Impact factor: 84.694

Review 8.  Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond.

Authors:  Veaceslav Boldescu; Mira A M Behnam; Nikos Vasilakis; Christian D Klein
Journal:  Nat Rev Drug Discov       Date:  2017-05-05       Impact factor: 84.694

9.  Global Interactomics Uncovers Extensive Organellar Targeting by Zika Virus.

Authors:  Etienne Coyaud; Charlene Ranadheera; Derrick Cheng; João Gonçalves; Boris J A Dyakov; Estelle M N Laurent; Jonathan St-Germain; Laurence Pelletier; Anne-Claude Gingras; John H Brumell; Peter K Kim; David Safronetz; Brian Raught
Journal:  Mol Cell Proteomics       Date:  2018-07-23       Impact factor: 5.911

10.  Catching a Moving Target: Comparative Modeling of Flaviviral NS2B-NS3 Reveals Small Molecule Zika Protease Inhibitors.

Authors:  Szymon Pach; Tim M Sarter; Rafe Yousef; David Schaller; Silke Bergemann; Christoph Arkona; Jörg Rademann; Christoph Nitsche; Gerhard Wolber
Journal:  ACS Med Chem Lett       Date:  2020-03-03       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.